Skip to main content
Back to Trials
NCT07219082NARecruitingAccepts Healthy Volunteers

Behavioral Safety and Fentanyl Education: BSAFE

San Francisco Department of Public Health

Start Date

8/11/2026

Completion Date

1/15/2030

Summary

BSAFE is a randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among people who use stimulants who may have unintentional fentanyl use (UFU). It includes an established overdose education curriculum within an Informational-Motivation-Behavior (IMB) model. This study will test the efficacy of BSAFE vs attention-control.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: 1. Aged 18 years or older, 2. Reports intentional cocaine or methamphetamine use ≥7 of past 30 days, 3. Urine positive for cocaine or methamphetamine and negative for opioids/fentanyl prior to enrollment 4. Be able to provide the names of at least 2 persons who can consistently locate their whereabouts. 5. Reports at least one suspected unintentional fentanyl use event, including unexpected sedation or unexpected fentanyl-positive bodily fluid drug testing result. Exclusion Criteria: 1. Reports past 30-day intentional use of any opioid or ongoing use of an opioid antagonist (e.g., naltrexone) 2. Intends to leave area in coming year, 3. Unable to communicate in English or Spanish, 4. Any other condition that, in the PI's judgment, interferes with safe study participation or adherence to study procedures.

Interventions

BEHAVIORAL

BSAFE Intervention

BEHAVIORAL

Attention control

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Drug OverdoseDrug Overdose Accidental

Locations

San Francisco Department of Public Health

San Francisco, California 94102

United States